| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $164.9M | — | +4.9% |
| Cost of Revenue | $2.9M | — | +20.0% |
| R&D Expense | $66.3M | — | +9.1% |
| SG&A Expense | $145.4M | — | +60.3% |
| Operating Income | -$49.6M | — | -1552.0% |
| Pre-tax Income | -$44.7M | — | -564.9% |
| Income Tax | -$13.0M | — | -18.5% |
| Net Income | -$31.8M | — | -254.6% |
| EPS (Basic) | -$0.30 | — | -257.9% |
| EPS (Diluted) | -$0.30 | — | -276.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $108.7M | -9.8% | +21.1% |
| Short-term Investments | $229.4M | -8.8% | -1.5% |
| Accounts Receivable | $39.1M | -34.6% | -36.8% |
| Inventory | $12.9M | +0.2% | -10.3% |
| Current Assets | $426.0M | -12.2% | -2.8% |
| Total Assets | $814.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.8M | — | -427.1% |
| Capital Expenditures | $201K | — | +93.3% |
| Investing Cash Flow | $4.5M | — | +243.2% |
| Financing Cash Flow | $760K | — | +101.9% |
| Free Cash Flow | -$17.0M | — | -437.8% |
| -3.7% |
| Current Liabilities | $149.2M | -10.2% | +4.3% |
| Total Liabilities | $176.9M | -6.3% | +8.4% |
| Stockholders' Equity | $638.0M | -1.5% | -6.6% |